In short
Cures Within Reach (CWR) states in its 2026 ReGRoW RFP that it will not consider LOIs or full proposals substantially written, wholly or partly, by large language models or other generative AI. CWR may remove an application from funding consideration if significant AI use is detected.
Varies by program. The rule is set in each program's guidelines, so check the one you are applying to.
For applicants
- Under the 2026 ReGRoW RFP, CWR will not consider LOI or full proposal applications that are substantially written, wholly or partly, by natural language processors, large language models, or other generative AI. CWR may remove an application from funding consideration if significant AI use is detected. The funder does support clinical trials that validate AI-driven drug-disease matches. [1]
For reviewers
Cures Within Reach has published no rules for reviewers.
Sources
CWR ReGRoW RFP 2026 (opens in a new tab)
While CWR is very supportive of clinical trials that validate AI-driven drug-disease matches, CWR will not consider LOI or full proposal applications that are substantially written, either in whole or in part, by natural language processors, large language models or other generative AI technologies. If significant AI use is detected, CWR may remove an application from funding consideration.
See Cures Within Reach's 2 open programs
This page summarizes what the funder has published and is not legal advice. Policies change, and one solicitation can add its own rules. Confirm against the funding announcement before you apply.